NYSE: THQ

abrdn Healthcare Opportunities Fund (THQ)

abrdn Healthcare Opportunities Fund is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE under the ticker THQ. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
THQ
Exchange
NYSE
SEC CIK
1604522
Official filings
SEC EDGAR

Research THQ

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is abrdn Healthcare Opportunities Fund's stock ticker?

abrdn Healthcare Opportunities Fund trades under the ticker symbol THQ on NYSE. Its SEC Central Index Key (CIK) is 1604522.

Where can I read abrdn Healthcare Opportunities Fund's SEC filings?

The THQ SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports abrdn Healthcare Opportunities Fund has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze THQ's financial statements?

The THQ Financials page shows abrdn Healthcare Opportunities Fund's income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does THQ compare with its peers and the market?

The THQ Peer Comparison page lines abrdn Healthcare Opportunities Fund up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.